Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

How to Address GMP Audit Non-Conformities and Corrective Actions

Posted on January 15, 2025 By digi

How to Address GMP Audit Non-Conformities and Corrective Actions

Step-by-Step Guide to Handling GMP Audit Non-Conformities

Introduction

Non-conformities identified during Good Manufacturing Practices (GMP) audits highlight gaps that can jeopardize compliance, product quality, and patient safety. Addressing these findings promptly and effectively is essential for maintaining regulatory approval and fostering continuous improvement. This guide provides a structured approach to resolving GMP audit non-conformities and implementing corrective actions.

Step 1: Understand the Non-Conformities

1. Review Audit Findings

Carefully analyze the audit report to understand the nature and severity of the non-conformities. These are typically categorized as:

  • Critical: Issues posing significant risks to product quality or patient safety.
  • Major: Serious deviations requiring prompt corrective action.
  • Minor: Less severe issues indicating areas for improvement.

2. Clarify Observations

If necessary, seek clarification from the auditors to fully comprehend the context and implications of each non-conformance.

Step 2: Conduct Root Cause Analysis (RCA)

1. Identify the Root Cause

Determine the underlying reason for each non-conformance using structured RCA tools such as:

  • 5 Whys Analysis: Asking “why” repeatedly to trace the issue to its root cause.
  • Fishbone Diagram: Exploring causes across categories like materials, methods, and personnel.
  • Failure Mode and Effects Analysis (FMEA): Identifying potential failures and their impact.
Also Read:  The Impact of Risk Management on GMP Compliance and Pharmaceutical Quality

2. Validate the Findings

Confirm the root cause by reviewing evidence and discussing findings

with relevant teams to ensure accuracy.

Step 3: Develop a Corrective Action Plan (CAP)

1. Define Corrective Actions

Create specific actions to address each non-conformance effectively. Ensure the actions:

  • Directly resolve the root cause
  • Comply with GMP guidelines
  • Are feasible and measurable

2. Include Preventive Measures

Design preventive actions to minimize the risk of recurrence. Examples include:

  • Revising Standard Operating Procedures (SOPs)
  • Enhancing employee training programs
  • Implementing automated monitoring systems

3. Assign Responsibilities and Timelines

Clearly define who is responsible for each action and establish realistic deadlines for implementation.

Step 4: Implement Corrective and Preventive Actions

1. Execute the Plan

Ensure responsible teams carry out the corrective and preventive actions as outlined in the CAP. Monitor progress through regular updates.

2. Communicate with Stakeholders

Keep auditors, regulatory authorities, and internal stakeholders informed about the status of corrective actions, especially for critical findings.

Also Read:  How to Prepare for a GMP Audit: A Comprehensive Guide

3. Document All Changes

Maintain detailed records of actions taken, including updates to SOPs, training materials, and workflows. This documentation will be essential during follow-up audits.

Step 5: Verify Effectiveness

1. Conduct Follow-Up Audits

Perform follow-up audits to ensure that corrective actions have effectively resolved the non-conformities and that preventive measures are functioning as intended.

2. Monitor Key Metrics

Track performance indicators such as:

  • Frequency of similar non-conformances
  • Time taken to close findings
  • Batch rejection rates

3. Gather Feedback

Solicit feedback from employees and auditors to identify any remaining gaps or areas for improvement.

Step 6: Foster a Culture of Compliance

1. Emphasize Continuous Improvement

Use audit findings as opportunities to enhance processes and systems. Encourage teams to view audits positively.

2. Strengthen Training Programs

Update training materials to incorporate lessons learned from audit findings, ensuring employees are well-equipped to maintain compliance.

3. Integrate CAPA with QMS

Align corrective and preventive actions with your Quality Management System (QMS) to ensure sustained compliance and operational excellence.

Common Challenges and Solutions

1. Inadequate Root Cause Analysis

Challenge: Superficial analyses can result in ineffective corrective actions. Solution: Use structured RCA tools and validate findings thoroughly.

Also Read:  Understanding ANVISA GMP Guidelines for Pharmaceutical Manufacturers in Brazil

2. Delayed Implementation

Challenge: Slow execution of corrective actions can lead to repeat findings. Solution: Assign clear responsibilities and set strict deadlines.

3. Resistance to Change

Challenge: Teams may resist implementing new processes or procedures. Solution: Communicate the benefits of changes and involve employees in decision-making.

Benefits of Effective Non-Conformance Management

1. Enhanced Compliance

Promptly addressing non-conformities ensures adherence to GMP standards and reduces regulatory risks.

2. Improved Operational Efficiency

Resolving issues identified during audits often leads to streamlined processes and better resource utilization.

3. Strengthened Reputation

Demonstrating a commitment to resolving findings builds trust with regulators, customers, and stakeholders.

Conclusion

Addressing GMP audit non-conformities requires a proactive and systematic approach. By understanding findings, conducting thorough root cause analyses, implementing effective corrective actions, and fostering a culture of compliance, organizations can strengthen their operations and maintain regulatory approval. Non-conformance management is not just about resolving issues—it’s an opportunity to enhance processes, build trust, and achieve long-term success in the pharmaceutical industry.

GMP Auditing Process Tags:GMP audit checklist, GMP certification process, GMP compliance guidelines, GMP documentation requirements, GMP Facility Requirements, GMP Guidelines for API Manufacturing, GMP Guidelines for Sterile Products, GMP in Pharmaceutical Packaging, GMP Inspection Preparation, GMP Non-Compliance Consequences, GMP Requirements for Equipment, GMP training for employees, GMP training programs, Good Manufacturing Practices (GMP), Pharmaceutical Batch Record Review, Pharmaceutical Change Control Procedures, Pharmaceutical Deviations Management, Pharmaceutical Documentation Practices, Pharmaceutical Environmental Monitoring, Pharmaceutical manufacturing standards, Pharmaceutical Process Validation, Pharmaceutical Product Quality Review, Pharmaceutical quality assurance, Pharmaceutical Quality Audits, Pharmaceutical Regulatory Compliance, Pharmaceutical Supply Chain Quality, Pharmaceutical Validation Processes, Quality control in pharmaceuticals, Quality Management Systems (QMS), Quality Risk Management in Pharma

Post navigation

Previous Post: How to Use Value Stream Mapping to Improve GMP in Pharmaceutical Manufacturing
Next Post: GMP Requirements for Equipment and Facility in Biopharmaceutical Manufacturing

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
  • 21 CFR Part 11 Checklist: Key Questions for System Owners and QA

    21 CFR Part 11 Checklist: Key Questions for System Owners and QA Comprehensive Part 11 Checklist for System Owners and… Read more

  • 21 CFR Part 11 Validation: How Much Is Enough for Low-Risk Systems?

    21 CFR Part 11 Validation: How Much Is Enough for Low-Risk Systems? Right-Sized Part 11 Validation for Low-Risk Electronic Systems… Read more

  • 21 CFR Part 11 Compliance for Cloud and SaaS GxP Systems

    21 CFR Part 11 Compliance for Cloud and SaaS GxP Systems Comprehensive Step-by-Step Guide to Achieving Part 11 Cloud Compliance… Read more

  • Electronic Records and Signatures: Aligning EU Annex 11 and 21 CFR Part 11

    Electronic Records and Signatures: Aligning EU Annex 11 and 21 CFR Part 11 Comprehensive Guide to Electronic Records and Signatures… Read more

  • Audit Trail Review Under 21 CFR Part 11: Practical Techniques and Schedules

    Audit Trail Review Under 21 CFR Part 11: Practical Techniques and Schedules Step-by-Step Guide to Effective Audit Trail Review for… Read more

A professional learning channel built for pharmaceutical, biotech, and life sciences professionals who want to strengthen inspection thinking and make confident quality decisions.

Welcome to GMP Scenarios

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Publisher Disclosure
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2026 Pharma GMP.

Powered by PressBook WordPress theme

Free GMP Video Content

Before You Leave...

Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.

  • Practical GMP scenarios
  • Inspection and compliance lessons
  • Short, useful, no-fluff videos
Visit GMP Scenarios on YouTube
Useful content only. No nonsense.